US Stock MarketDetailed Quotes

PPBT Purple Biotech

Watchlist
  • 2.640
  • -0.020-0.75%
Close Apr 1 16:00 ET
  • 2.670
  • +0.030+1.13%
Post 20:01 ET
6.99MMarket Cap-0.53P/E (TTM)

Purple Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-51.49%10.8M
-83.79%1.02M
-62.88%2.13M
-36.59%3.26M
-12.81%4.47M
-1.47%22.27M
-5.06%6.27M
13.11%5.75M
43.04%5.14M
-30.13%5.12M
Selling and administrative expenses
-39.41%2.94M
-50.95%310K
-32.21%785K
-39.51%865K
-35.78%1.04M
-18.75%4.84M
-56.71%632K
-28.34%1.16M
-5.11%1.43M
17.77%1.62M
-General and administrative expense
-39.41%2.94M
----
----
----
----
-18.75%4.84M
----
----
----
----
Research and development costs
-55.27%7.62M
-91.26%458K
-70.63%1.35M
-35.47%2.39M
-2.14%3.42M
4.38%17.03M
8.76%5.24M
32.44%4.59M
77.87%3.71M
-41.23%3.5M
Depreciation amortization depletion
-5.58%186K
----
----
----
----
-1.99%197K
----
----
----
----
-Depreciation and amortization
-5.58%186K
----
----
----
----
-1.99%197K
----
----
----
----
Other operating expenses
-68.37%62K
----
----
----
----
63.33%196K
----
----
----
----
Operating profit
51.49%-10.8M
83.79%-1.02M
62.88%-2.13M
36.59%-3.26M
12.81%-4.47M
1.47%-22.27M
5.06%-6.27M
-13.11%-5.75M
-43.04%-5.14M
30.13%-5.12M
Net non-operating interest income expense
87.58%-212K
97.22%-72K
-155.06%-381K
488.00%97K
212.79%685K
-418.47%-1.71M
-1,133.07%-2.59M
198.28%692K
-165.79%-25K
1,360.00%219K
Non-operating interest income
-45.15%260K
76.06%-152K
-81.64%130K
-1.63%121K
152.52%702K
-10.90%474K
-556.83%-635K
185.48%708K
38.20%123K
396.43%278K
Non-operating interest expense
-26.79%41K
-205.99%-511K
3,093.75%511K
-83.78%24K
-71.19%17K
-16.42%56K
-307.32%-167K
0.00%16K
190.20%148K
43.90%59K
Total other finance cost
-79.72%431K
----
----
----
----
3,092.96%2.13M
----
----
----
----
Other net income (expense)
-6.62%3.74M
673K
1.85M
744K
1,203.26%4M
Gain on sale of security
-1.57%3.94M
--673K
--1.85M
--946K
----
1,203.26%4M
----
----
----
----
Special income (charges)
---202K
--0
--0
---202K
----
--0
--0
--0
--0
----
-Write off
--202K
--0
--0
--202K
----
--0
--0
--0
--0
----
Income before tax
63.56%-7.28M
91.46%-415K
86.79%-668K
53.20%-2.42M
22.88%-3.78M
8.19%-19.98M
19.59%-4.86M
-4.25%-5.06M
-45.27%-5.16M
32.98%-4.9M
Income tax
Net income
63.56%-7.28M
91.46%-415K
86.79%-668K
53.20%-2.42M
22.88%-3.78M
8.19%-19.98M
19.59%-4.86M
-4.25%-5.06M
-45.27%-5.16M
32.98%-4.9M
Net income continuous Operations
63.56%-7.28M
91.46%-415K
86.79%-668K
53.20%-2.42M
22.88%-3.78M
8.19%-19.98M
19.59%-4.86M
-4.25%-5.06M
-45.27%-5.16M
32.98%-4.9M
Minority interest income
59.79%-39K
83.87%-5K
73.68%-5K
54.55%-10K
24.00%-19K
-5.43%-97K
3.13%-31K
24.00%-19K
-37.50%-22K
-31.58%-25K
Net income attributable to the parent company
63.58%-7.24M
91.51%-410K
86.83%-663K
53.19%-2.41M
22.88%-3.76M
8.25%-19.88M
19.68%-4.83M
-4.39%-5.04M
-45.31%-5.14M
33.15%-4.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
63.58%-7.24M
91.51%-410K
86.83%-663K
53.19%-2.41M
22.88%-3.76M
8.25%-19.88M
19.68%-4.83M
-4.39%-5.04M
-45.31%-5.14M
33.15%-4.88M
Basic earnings per share
-145.87%-44.158
95.46%-0.1586
91.58%-0.39
64.00%-1.8
44.00%-2.8
25.07%-17.96
47.12%-3.49
14.26%-4.63
-25.00%-5
39.02%-5
Diluted earnings per share
-177.84%-49.9
71.35%-1
91.58%-0.39
64.00%-1.8
44.00%-2.8
25.07%-17.96
47.12%-3.49
14.26%-4.63
-25.00%-5
39.02%-5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -51.49%10.8M-83.79%1.02M-62.88%2.13M-36.59%3.26M-12.81%4.47M-1.47%22.27M-5.06%6.27M13.11%5.75M43.04%5.14M-30.13%5.12M
Selling and administrative expenses -39.41%2.94M-50.95%310K-32.21%785K-39.51%865K-35.78%1.04M-18.75%4.84M-56.71%632K-28.34%1.16M-5.11%1.43M17.77%1.62M
-General and administrative expense -39.41%2.94M-----------------18.75%4.84M----------------
Research and development costs -55.27%7.62M-91.26%458K-70.63%1.35M-35.47%2.39M-2.14%3.42M4.38%17.03M8.76%5.24M32.44%4.59M77.87%3.71M-41.23%3.5M
Depreciation amortization depletion -5.58%186K-----------------1.99%197K----------------
-Depreciation and amortization -5.58%186K-----------------1.99%197K----------------
Other operating expenses -68.37%62K----------------63.33%196K----------------
Operating profit 51.49%-10.8M83.79%-1.02M62.88%-2.13M36.59%-3.26M12.81%-4.47M1.47%-22.27M5.06%-6.27M-13.11%-5.75M-43.04%-5.14M30.13%-5.12M
Net non-operating interest income expense 87.58%-212K97.22%-72K-155.06%-381K488.00%97K212.79%685K-418.47%-1.71M-1,133.07%-2.59M198.28%692K-165.79%-25K1,360.00%219K
Non-operating interest income -45.15%260K76.06%-152K-81.64%130K-1.63%121K152.52%702K-10.90%474K-556.83%-635K185.48%708K38.20%123K396.43%278K
Non-operating interest expense -26.79%41K-205.99%-511K3,093.75%511K-83.78%24K-71.19%17K-16.42%56K-307.32%-167K0.00%16K190.20%148K43.90%59K
Total other finance cost -79.72%431K----------------3,092.96%2.13M----------------
Other net income (expense) -6.62%3.74M673K1.85M744K1,203.26%4M
Gain on sale of security -1.57%3.94M--673K--1.85M--946K----1,203.26%4M----------------
Special income (charges) ---202K--0--0---202K------0--0--0--0----
-Write off --202K--0--0--202K------0--0--0--0----
Income before tax 63.56%-7.28M91.46%-415K86.79%-668K53.20%-2.42M22.88%-3.78M8.19%-19.98M19.59%-4.86M-4.25%-5.06M-45.27%-5.16M32.98%-4.9M
Income tax
Net income 63.56%-7.28M91.46%-415K86.79%-668K53.20%-2.42M22.88%-3.78M8.19%-19.98M19.59%-4.86M-4.25%-5.06M-45.27%-5.16M32.98%-4.9M
Net income continuous Operations 63.56%-7.28M91.46%-415K86.79%-668K53.20%-2.42M22.88%-3.78M8.19%-19.98M19.59%-4.86M-4.25%-5.06M-45.27%-5.16M32.98%-4.9M
Minority interest income 59.79%-39K83.87%-5K73.68%-5K54.55%-10K24.00%-19K-5.43%-97K3.13%-31K24.00%-19K-37.50%-22K-31.58%-25K
Net income attributable to the parent company 63.58%-7.24M91.51%-410K86.83%-663K53.19%-2.41M22.88%-3.76M8.25%-19.88M19.68%-4.83M-4.39%-5.04M-45.31%-5.14M33.15%-4.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 63.58%-7.24M91.51%-410K86.83%-663K53.19%-2.41M22.88%-3.76M8.25%-19.88M19.68%-4.83M-4.39%-5.04M-45.31%-5.14M33.15%-4.88M
Basic earnings per share -145.87%-44.15895.46%-0.158691.58%-0.3964.00%-1.844.00%-2.825.07%-17.9647.12%-3.4914.26%-4.63-25.00%-539.02%-5
Diluted earnings per share -177.84%-49.971.35%-191.58%-0.3964.00%-1.844.00%-2.825.07%-17.9647.12%-3.4914.26%-4.63-25.00%-539.02%-5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +29.96%
Sample Name
Sample Code
 +24.59%
Sample Name
Sample Code
 +20.05%
4
Tibet Duo Rui Pharmaceutical
301075
+20.02%
5
Chengda Pharmaceuticals
301201
+20.01%
Unlock Now

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 306.020
Sample Name
Sample Code
 268.460
Sample Name
Sample Code
 11.840
4
Microsoft
MSFT
382.190
5
Alphabet-C
GOOG
158.880
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 268.460
Sample Name
Sample Code
 382.190
Sample Name
Sample Code
 158.880
4
Meta Platforms
META
586.000
5
NVIDIA
NVDA
110.150
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 13.320
Sample Name
Sample Code
 7.560
Sample Name
Sample Code
 6.640
4
Cipher Mining
CIFR
2.460
5
Hive Blockchain
HIVE
1.540
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -